Salah-Eddin Al-Batran

Salah-Eddin Al-Batran

UNVERIFIED PROFILE

Are you Salah-Eddin Al-Batran?   Register this Author

Register author
Salah-Eddin Al-Batran

Salah-Eddin Al-Batran

Publications by authors named "Salah-Eddin Al-Batran"

Are you Salah-Eddin Al-Batran?   Register this Author

90Publications

2998Reads

50Profile Views

Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective.

J Gastric Cancer 2019 Jun 24;19(2):148-156. Epub 2019 May 24.

Center of Esophageal and Gastric Surgery, Agaplesion Markus Hospital, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5230/jgc.2019.19.e19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589422PMC
June 2019

Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine FOLFIRINOX in advanced pancreatic cancer: a systematic review.

Ther Adv Med Oncol 2019 19;11:1758835919850367. Epub 2019 May 19.

Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919850367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535755PMC
May 2019

Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials.

Eur J Cancer 2019 Jan 14;107:115-123. Epub 2018 Dec 14.

Institute of Clinical Cancer Research (IKF), University Cancer Center, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183151
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.013DOI Listing
January 2019

Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:e88-e95. Epub 2019 May 17.

1 Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_236827DOI Listing
January 2019

Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions.

Cancer Treat Rev 2018 Sep 18;69:90-100. Epub 2018 Jun 18.

Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.06.012DOI Listing
September 2018

Multimodal treatment in locally advanced gastric cancer.

Updates Surg 2018 Jun 26;70(2):173-179. Epub 2018 Jun 26.

Hôpitaux Universitaires de Genève, Service de Chirurgie viscéral, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13304-018-0539-zDOI Listing
June 2018

Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma.

Eur J Cancer 2018 02 20;90:26-33. Epub 2017 Dec 20.

3rd Department of Internal Medicine (Hematology/Medical Oncology), Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.11.020DOI Listing
February 2018

Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?

Hematol Oncol Clin North Am 2017 06 29;31(3):441-452. Epub 2017 Mar 29.

Department of Hematology and Oncology, Klinikum rechts der Isar der TU München, Ismaninger Straße 22, München 81675, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2017.01.004DOI Listing
June 2017

Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine.

Oncol Res Treat 2015 20;38(11):596-603. Epub 2015 Oct 20.

Klinik fx00FC;r Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000441310DOI Listing
September 2016

Reply to the Letter to the Editor.

Gastric Cancer 2016 Jan 20;19(1):320-1. Epub 2015 Aug 20.

III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0532-xDOI Listing
January 2016

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

J Clin Oncol 2016 Jan 2;34(3):244-50. Epub 2015 Nov 2.

Heikki Joensuu and Petri Bono, Comprehensive Cancer Center Helsinki; Heikki Joensuu, Harri Sihto, and Petri Bono, University of Helsinki, Helsinki; Raija Kallio, Oulu University Hospital, Oulu; Jouni Junnila, 4Pharma, Turku, Finland; Mikael Eriksson and Thor Alvegård, Lund University, Lund; Bengt Nilsson, Sahlgrenska University Hospital, Gothenburg, Sweden; Kirsten Sundby Hall, Oslo University Hospital, Oslo, Norway; Annette Reichardt, Daniel Pink, and Peter Reichardt, Sarkomzentrum Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Berlin; Jörg T. Hartmann, Franziskus Hospital, Catholic Hospital Consortium Ostwestfalen, Bielefeld; Giuliano Ramadori, University of Göttingen, Göttingen; Peter Hohenberger, Mannheim University Medical Center, Mannheim; Salah-Eddin Al-Batran, Klinik für Onkologie und Hämatologie am Krankenhaus Nordwest, Frankfurt; Marcus Schlemmer, University Hospital Großhadern, Ludwig Maximilians University, Munich; Sebastian Bauer, Sarcoma Center, West German Cancer Center, Essen; and Eva Wardelmann, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/10/26/JCO.2015.62
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.62.9170
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.9170DOI Listing
January 2016

Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer.

J Clin Oncol 2015 Nov 10;33(32):3718-26. Epub 2015 Aug 10.

Dominik P. Modest, Sebastian Stintzing, and Volker Heinemann, University Hospital Grosshadern; Andreas Jung and Thomas Kirchner, University of Munich, Munich; Dominik P. Modest, Sebastian Stintzing, Volker Heinemann, Andreas Jung, and Thomas Kirchner, German Cancer Consortium and German Cancer Research Centre, Heidelberg; Ludwig Fischer von Weikersthal, Gesundheitszentrum St Marien, Amberg; Thomas Decker, Oncological Practice, Ravensburg; Alexander Kiani, Klinikum Bayreuth, Bayreuth; Ursula Vehling-Kaiser, Oncological Practice, Landshut; Salah-Eddin Al-Batran, Krankenhaus Nordwest, Frankfurt am Main; Tobias Heintges, Städtisches Klinikum Neuss, Neuss; Christian Lerchenmüller, Oncological Practice, Münster; Christoph Kahl, Staedtisches Klinikum Magdeburg, Magdeburg; Gernot Seipelt, Oncological Practice, Bad Soden; Frank Kullmann, Klinikum Weiden, Weiden; Martina Stauch, Oncological Practice, Kronach; Svantje Held, ClinAssess, Leverkusen; Markus Möhler, Johannes-Gutenberg Universität and German Cancer Consortium, Mainz, Germany; and Werner Scheithauer, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.2887DOI Listing
November 2015

Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer.

Eur J Cancer 2015 Sep 24;51(14):1918-26. Epub 2015 Jul 24.

Department of Surgery, Klinikum rechts der Isar der Technischen Universitaet Muenchen, Muenchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.07.002DOI Listing
September 2015

Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.

J Clin Oncol 2015 Aug 29;33(22):2444-9. Epub 2015 Jun 29.

Ralf-Dieter Hofheinz and Deniz Gencer, University Hospital Mannheim, Mannheim; Holger Schulz, Praxis Internistische Onkologie und Hämatologie, Frechen; Michael Stahl, Kliniken Essen-Mitte, Essen; Susanna Hegewisch-Becker, Hämatologisch-Onkologische Praxis Eppendorf, Hamburg; Luisa Mantovani Loeffler, Onkologie, Haematologie und Palliativmedizin, Leipzig; Ursula Kronawitter, Onkologische Schwerpunktpraxis, Traunstein; Georg Bolz, Medizinische Klinik I, Ludwigshafen; Jochem Potenberg, Waldkrankenhaus Spandau, Berlin; Felix Tauchert and Salah-Eddin Al-Batran, Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main; and Andreas Schneeweiss, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.4587DOI Listing
August 2015

First-line nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer from routine clinical practice.

In Vivo 2014 Nov-Dec;28(6):1135-40

Department of Internal Medicine, Herdecke Community Hospital, Herdecke, Germany.

View Article

Download full-text PDF

Source
July 2015

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.

BMC Cancer 2015 Apr 17;15:300. Epub 2015 Apr 17.

Institute of clinical research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Steinbacher Hohl 2-26, 60488, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1310-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404179PMC
April 2015

Afatinib with concurrent radiotherapy in a patient with metastatic non-small cell lung cancer.

Oncol Res Treat 2014 14;37(5):262-5. Epub 2014 Apr 14.

Department of Oncology and Hematology, Krankenhaus Nordwest, UCT University Cancer Center, Frankfurt/M., Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362488DOI Listing
January 2015

Nab-paclitaxel for metastatic pancreatic cancer: clinical outcomes and potential mechanisms of action.

Oncol Res Treat 2014 7;37(3):128-34. Epub 2014 Feb 7.

Krankenhaus Nordwest, UCT University Cancer Center Frankfurt, Frankfurt/Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000358890DOI Listing
December 2014

Recent advances and future trends in the targeted therapy of metastatic gastric cancer.

Expert Rev Gastroenterol Hepatol 2014 Jul 25;8(5):555-69. Epub 2014 Mar 25.

Krankenhaus Nordwest, UCT-University Cancer Center Frankfurt, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2014.902304DOI Listing
July 2014

The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing.

J Transl Med 2014 Jun 6;12:160. Epub 2014 Jun 6.

Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center Frankfurt, Steinbacher Hohl 2-26, 60488, Frankfurt/Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-12-160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059883PMC
June 2014

Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.

J Cancer Res Clin Oncol 2014 May 21;140(5):829-37. Epub 2014 Feb 21.

III. Medizinische Klinik, Hämatologie und Onkologie, Universitätsmedizin Mannheim, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1619-1DOI Listing
May 2014

The role of radiation therapy for resectable adenocarcinoma of the gastroesophageal junction.

Oncologist 2014 Apr;19(4):431

Krankenhaus Nordwest, UCT - University Cancer Center Frankfurt, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2013-0424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983825PMC
April 2014

Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Gastric Cancer 2014 Jan 28;17(1):181-7. Epub 2013 Feb 28.

III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-013-0242-1DOI Listing
January 2014

Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.

J Clin Oncol 2013 Nov 16;31(31):3935-43. Epub 2013 Sep 16.

Atsushi Ohtsu, National Cancer Center Hospital East, Kashiwa; Keisho Chin, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo; Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan; Jaffer A. Ajani, University of Texas MD Anderson Cancer Center, Houston, TX; Tarek Sahmoud, Heind Smith, Syed Rizvi, David Lebwohl, Novartis Pharmaceuticals, Florham Park, NJ; Yu-Xian Bai, Tumor Hospital of Harbin Medical University, Harbin; Hong-Ming Pan, Sir Run Run Shaw Hospital, Zhejiang; Lin Shen, Peking University Cancer Hospital, Beijing, People's Republic of China; Yung-Jue Bang, Seoul National University College of Medicine; Hyun-Cheol Chung, Yonsei Cancer Center, Yonsei University College of Medicine; Yeul Hong Kim, Korea University Anam Hospital, Seoul, South Korea; Kun-Huei Yeh, National Taiwan University Hospital, Taipei, Taiwan, Republic of China; David Ferry, New Cross Hospital, Wolverhampton, United Kingdom; Niall C. Tebbutt, Austin Health, Heidelberg, Australia; Salah-Eddin Al-Batran, Institute for Clinical Oncology Research, Krankenhaus Nordwest, UCT University Cancer Center, Frankfurt, Germany; Chiara Costantini, Novartis Pharma AG, Basel, Switzerland; Eric Van Cutsem, University Hospitals Leuven and KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.3552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950503PMC
November 2013

Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.

Int J Cancer 2013 Oct 7;133(8):1825-31. Epub 2013 May 7.

Department of Internal Medicine, 3, Klinikum Nürnberg, Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28209DOI Listing
October 2013

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.

Cancer Med 2013 Jun 2;2(3):325-33. Epub 2013 Apr 2.

Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.77DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699844PMC
June 2013

Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases.

Onkologie 2012 17;35(9):505-8. Epub 2012 Aug 17.

Institute of Clinical Research at the Krankenhaus Nordwest and Department of Oncology and Hematology, University Cancer Center Frankfurt, Frankfurt/M., Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000341841DOI Listing
March 2013

Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval.

J Cancer Res Clin Oncol 2013 Feb 19;139(2):337-45. Epub 2012 Oct 19.

TagesTherapieZentrum (TTZ) am Interdisziplinären Tumorzentrum Mannheim (ITM) & III. Medizinische Klinik für Hämatologie und Onkologie, Universitätsmedizin Mannheim, Universität Heidelberg, 68167 Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-012-1335-7DOI Listing
February 2013

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer.

BMC Cancer 2012 Nov 15;12:524. Epub 2012 Nov 15.

Department of Hematology and Oncology, Institute of clinical research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529672PMC
November 2012

mTOR as a therapeutic target in patients with gastric cancer.

Int J Cancer 2012 Feb 5;130(3):491-6. Epub 2011 Oct 5.

Department of Hematology and Oncology, Krankenhaus Nordwest, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.26396
Publisher Site
http://dx.doi.org/10.1002/ijc.26396DOI Listing
February 2012

Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer.

Oncology 2011 14;80(1-2):130-4. Epub 2011 Jun 14.

Department of Hematology and Oncology, Krankenhaus Nordwest, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000329063DOI Listing
September 2011

Trastuzumab plus chemotherapy in gastric cancer overexpressing HER-2 and EGFR: a case report.

Onkologie 2011 17;34(1-2):42-5. Epub 2011 Jan 17.

Klinik für Onkologie und Hämatologie, Krankenhaus Nordwest, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000323345DOI Listing
July 2011

Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.

Onkologie 2010 20;33(10):512-8. Epub 2010 Sep 20.

TagesTherapieZentrum am Interdisziplinären Tumorzentrum Mannheim und III. Medizinische Klinik, Universitätsmedizin Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000319699DOI Listing
February 2011

An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumors.

Clin Cancer Res 2010 Sep 3;16(18):4666-74. Epub 2010 Aug 3.

Universitätsmedizin Mannheim, Heidelberg University, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0318DOI Listing
September 2010

Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer.

Cancer 2010 Jun;116(11):2511-8

Quality of Life Working Group of the AIO and Oncology and Hematology Clinic, Krankenhaus Nordwest, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25064DOI Listing
June 2010

Accomplishments in 2008 in the management of advanced gastroesophageal cancer.

Gastrointest Cancer Res 2009 Sep;3(5 Supplement 2):S58-61

Department of Hematology and Oncology, Krankenhaus Nordwest, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791384PMC
September 2009

Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.

Gynecol Oncol 2009 Feb 6;112(2):384-8. Epub 2008 Dec 6.

Klinik für Onkologie und Hämatologie, Krankenhaus Nordwest GmbH, Steinbacher Hohl 2-26, D-60488 Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.11.001DOI Listing
February 2009

[Treatment of gastric cancer].

Onkologie 2008 14;31 Suppl 5:32-9. Epub 2008 Nov 14.

Nationales Zentrum für Tumorerkrankungen, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000163075DOI Listing
February 2009

Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.

Onkologie 2008 May 10;31(5):271-81. Epub 2008 Apr 10.

Onkologisches Zentrum, III. Medizinische Klinik, Medizinische Fakultat Mannheim, Universitat Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000122590DOI Listing
May 2008

Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 year.

Support Cancer Ther 2007 Sep;4(4):203-10

Department of Hematology, Oncology and Tumor Immunology, Robert Roessle Klinik der Charité - Universitaetsmedizin Berlin, Campus Buch am HELIOS-Klinikum Berlin-Buch, Berlin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/SCT.2007.n.016DOI Listing
September 2007

Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.

Onkologie 2007 May 24;30(5):235-40. Epub 2007 Apr 24.

Abteilung Onkologie/Hämatologie/Immunologie/Rheumatologie/Pulmologie, Medizinische Klinik II, Eberhard-Karls-Universität, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000100828DOI Listing
May 2007

Chemotherapy for advanced gastric cancer.

J Clin Oncol 2007 Feb;25(6):729; author reply 730

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.09.4896DOI Listing
February 2007

Pharmacogenetics of extraordinary responses to 5-FU/cisplatin chemotherapy in advanced gastric cancer -- report of 2 cases.

Onkologie 2005 Nov;28(11):589-92

Medizinische Klinik II, Onkologie, Hämatologie und Knochenmarkstransplantation, Universitätsklinikum Hamburg-Eppendorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000088916DOI Listing
November 2005